March 5, 2019
Antolrx Announces Pfizer Exercises Option to License Immune Tolerance Therapy For Potential Treatment of Type 1 Diabetes
February 4, 2019
Breakthrough T1D STATEMENT ON UNITED HEALTHCARE INSULIN PUMP AGREEMENT WITH MEDTRONIC
January 31, 2019
Breakthrough T1D Statement on the United States Department of Health and Human Services Announcement on Drug Rebates
January 31, 2019
Breakthrough T1D Leads Research to Develop a Vaccine for Viral Infections That Could Prevent Type 1 Diabetes
January 16, 2019
Breakthrough T1D Ambassador Eric Tozer set to participate in the 2019 World Marathon Challenge
December 20, 2018
Mount Sinai Researchers Discover New Drug Cocktail That Increases Human Beta Cell Proliferation at Rapid Rates
December 19, 2018
Pandion Therapeutics Launches Type 1 Diabetes Focused Program with Investment from Breakthrough T1D T1D Fund
November 14, 2018
Breakthrough T1D URGES INSURANCE PLANS TO LOWER INSULIN COSTS BY PASSING DRUG REBATES TO PEOPLE WITH DIABETES
November 13, 2018
Type 1 Diabetes Champion Lance Bergstein To Compete in the Circuit of the Americas 24H Series Race
November 1, 2018
Breakthrough T1D Launches “I’m the Type” Campaign for National Diabetes Awareness Month
